Skip to main content

Table 3 Toxicity

From: Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

  Grade 1 Grade 2 Grade 3 Grade 4
Performance status 1 4 1  
Fatigue 2 3 1  
Leucopenia     6
Neutropenia     6
Lymphopenia     6
Thrombopenia    2 1
Anemia   6   
Nausea 1 4   
Diarrhea 2 2 1  
Vomiting 2   1  
Infections 2   1  
Alopecia   6   
Dermatitis 2 1   
Allergic reaction 3    
Low sodium levels 2   3 1
  1. No grade 3–4 events were associated with Interleukin-2 treatment. Grade is referring to Common Terminology Criteria for Adverse Events (CTCAE) v. 3.0. Digits in the table are referring to number of patients with the given adverse event.